FDA questions AstraZeneca #39;s Exanta NEW YORK, September 9 (New Ratings) - The FDA has raised questions regarding AstraZenecas (AZN.NYS) blood thinner, Exanta. The leading pharmaceutical companys hopes had been pinned on Exanta, which  

Which of the following sections of a newspaper would this article likely appear in? World News, Sports, Business, or Science and Technology? 